Team:KAIT JAPAN
From 2014.igem.org
(9 intermediate revisions not shown) | |||
Line 3: | Line 3: | ||
[[File:KAIT Japan 2014 iGEMRogo.png|center|link=https://2014.igem.org/Main_Page]] | [[File:KAIT Japan 2014 iGEMRogo.png|center|link=https://2014.igem.org/Main_Page]] | ||
{|style= width="100%" align="center" | {|style= width="100%" align="center" | ||
- | | | + | | |
- | {|style="background:# | + | {|style="background:#FFFFFF; margin:0.1em" |
- | !align="center"|[[File: | + | !align="center"|[[File:New home t.jpg|link=Team:KAIT JAPAN]] |
[[Team:KAIT JAPAN|Home]] | [[Team:KAIT JAPAN|Home]] | ||
|} | |} | ||
| | | | ||
- | {|style="background:# | + | {|style="background:#FFFFFF; margin:0.1em" |
- | !align="center"|[[File: | + | !align="center"|[[File:New Team1.jpg|link=Team:KAIT_Japan/Team]] |
[[Team:KAIT_Japan/Team|Team]] | [[Team:KAIT_Japan/Team|Team]] | ||
|} | |} | ||
| | | | ||
- | {|style="background:# | + | {|style="background:#FFFFFF; margin:0.1em" |
- | !align="center"|[[File: | + | !align="center"|[[File:New 考える人.jpg|link=Team:KAIT_Japan/Project]] |
[[Team:KAIT_Japan/Project|Project]] | [[Team:KAIT_Japan/Project|Project]] | ||
|} | |} | ||
| | | | ||
- | {|style="background:# | + | {|style="background:#FFFFFF; margin:0.1em" |
- | !align="center"|[[File: | + | !align="center"|[[File:New 歯車.jpg|link=Team:KAIT_Japan/Parts]] |
[[Team:KAIT_Japan/Parts|Parts]] | [[Team:KAIT_Japan/Parts|Parts]] | ||
|} | |} | ||
| | | | ||
- | {|style="background:# | + | {|style="background:#FFFFFF; margin:0.1em" |
- | !align="center"|[[File: | + | !align="center"|[[File:New 111111111111111.jpg|link=Team:KAIT_Japan/Protocol]] |
[[Team:KAIT_Japan/Protocol|Protocol]] | [[Team:KAIT_Japan/Protocol|Protocol]] | ||
|} | |} | ||
| | | | ||
- | {|style="background:# | + | {|style="background:#FFFFFF; margin:0.1em" |
- | !align="center"|[[File: | + | !align="center"|[[File:Ff.jpg|link=Team:KAIT_Japan/Notebook]] |
[[Team:KAIT_Japan/Notebook|Notebook]] | [[Team:KAIT_Japan/Notebook|Notebook]] | ||
|} | |} | ||
| | | | ||
- | {|style="background:# | + | {|style="background:#FFFFFF; margin:0.1em" |
- | !align="center"|[[File: | + | !align="center"|[[File:New 結果.jpg|link=Team:KAIT_Japan/Results]] |
[[Team:KAIT_Japan/Results|Results]] | [[Team:KAIT_Japan/Results|Results]] | ||
|} | |} | ||
| | | | ||
- | {|style="background:# | + | {|style="background:#FFFFFF; margin:0.1em" |
- | !align="center"|[[File: | + | !align="center"|[[File:New new 危険.jpg|link=Team:KAIT_Japan/Safety]] |
[[Team:KAIT_Japan/Safety|Safety]] | [[Team:KAIT_Japan/Safety|Safety]] | ||
|} | |} | ||
| | | | ||
- | {|style="background:# | + | {|style="background:#FFFFFF; margin:0.1em" |
- | !align="center"|[[File: | + | !align="center"|[[File:New new ひと.jpg|link=Team:KAIT_Japan/Human_Practice]] |
[[Team:KAIT_Japan/Human_Practice|Human Practice]] | [[Team:KAIT_Japan/Human_Practice|Human Practice]] | ||
|} | |} | ||
| | | | ||
|} | |} | ||
- | {| style="width:98.5%; margin-left:0.2em; border-color:#00BFFF; border-style:solid; border-collapse:collapse; background-color:# | + | {| style="width:98.5%; margin-left:0.2em; border-color:#00BFFF; border-style:solid; border-collapse:collapse; background-color:#ffffe0; text-align:left" |
| style="width:30% style="vertical-align:top" | | | style="width:30% style="vertical-align:top" | | ||
https://static.igem.org/mediawiki/2012/d/d6/KAIT_Japan-photo-side.jpg<br> | https://static.igem.org/mediawiki/2012/d/d6/KAIT_Japan-photo-side.jpg<br> | ||
Line 61: | Line 61: | ||
------ | ------ | ||
<span style="color:#f30">'''News'''</span> | <span style="color:#f30">'''News'''</span> | ||
- | + | :9/1 Team <span style="color:#ff0000">'''OPEN!'''</span> | |
+ | :9/1 Safety <span style="color:#ff0000">'''OPEN!'''</span> | ||
+ | :8/25 Protocol <span style="color:#ff0000">'''OPEN!'''</span> | ||
+ | :8/25 Notebook <span style="color:#ff0000">'''OPEN!'''</span> | ||
------ | ------ | ||
<span style="color:#f30">'''Contacts'''</span> | <span style="color:#f30">'''Contacts'''</span> | ||
Line 70: | Line 73: | ||
------ | ------ | ||
<span style="color:#f30">'''Sponsors'''</span> | <span style="color:#f30">'''Sponsors'''</span> | ||
+ | |||
+ | :[[File:KAIT_Japan_2014_Yume.png|link=http://www.kait.jp/yumepro/]] | ||
+ | |||
+ | |||
+ | [[File:KAIT_Japan_2014_Cosmo.png|link=http://www.cosmobio.co.jp/index_e.asp]] | ||
| style="border-left:3px solid #00BFFF" valign="top" | | | style="border-left:3px solid #00BFFF" valign="top" | | ||
Line 76: | Line 84: | ||
'''[[Team:KAIT_Japan/Project|Project]]:<span style="color:#f33">Abstract'''</span> | '''[[Team:KAIT_Japan/Project|Project]]:<span style="color:#f33">Abstract'''</span> | ||
<br> | <br> | ||
- | + | <font size="4">~Cure allergy system~</font> | |
- | + | Acquired immune system is one of two main immunity strategies in vertebrates. | |
- | + | In this system , Helper T cells work mainly. | |
- | + | Th1 cells and Th2 cells keep balance mutually, and two cells usually control immune response. When this balance collapses and became the Th2 predominance, IL-5 is secreted excessively from Th2, and eosonophil,basophil,and mast cells are activated by IL-5. These activated cells secrete inflammatory materials that cause allergic symptoms such as bronchial asthma and atopic dermatitis. On the other hand, by stimulation of IL-12, naïve T cell differentiates into Th1 cell and Th1 cell alleviates allergic symptoms. We though it is possible to ameliorate allergic symptoms by decreasing IL-5 and increasing IL-12. Focusing on ligand dependent dimerization of IL-5 receptor ,we try to make IL5 independent expression system . | |
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + |
Latest revision as of 14:54, 16 October 2014
|
|
|
|
|
|
|
|
|
News
Contacts
Sponsors |
Project:Abstract
Acquired immune system is one of two main immunity strategies in vertebrates. In this system , Helper T cells work mainly. Th1 cells and Th2 cells keep balance mutually, and two cells usually control immune response. When this balance collapses and became the Th2 predominance, IL-5 is secreted excessively from Th2, and eosonophil,basophil,and mast cells are activated by IL-5. These activated cells secrete inflammatory materials that cause allergic symptoms such as bronchial asthma and atopic dermatitis. On the other hand, by stimulation of IL-12, naïve T cell differentiates into Th1 cell and Th1 cell alleviates allergic symptoms. We though it is possible to ameliorate allergic symptoms by decreasing IL-5 and increasing IL-12. Focusing on ligand dependent dimerization of IL-5 receptor ,we try to make IL5 independent expression system . |